MedTrace Logo

Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

NCT00659724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2025-07-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect information on the ease of use and thrombogenicity of the Polyflux HD-C4 Big and Fresenius Optiflux 180NR or 200NR dialyzers under conditions of routine clinical use for hemodialysis.

Conditions

  • Chronic Kidney Failure

Sponsors & Collaborators

  • Advanced Dialysis Center of Potomac

    collaborator INDUSTRY

  • Advanced Dialysis Center of Easton

    collaborator INDUSTRY

  • Gambro Renal Products, Inc.

    collaborator INDUSTRY

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Vantive Health LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00659724 on ClinicalTrials.gov